Calling Them “Vanity Drugs,” Some Insurers Refuse to Cover New Anti-Obesity Drugs
In an interview with Pharmacy Times, Ron Lanton III, Esq., principal at Lanton Law, discussed why insurers are refusing to [...]
Advertisement
In an interview with Pharmacy Times, Ron Lanton III, Esq., principal at Lanton Law, discussed why insurers are refusing to [...]
